Early milestones and neurodevelopment in children with mitochondrial disease

AIM: To quantify neurodevelopmental functioning in children with primary mitochondrial disease (MtD), and to assess relationships with other clinical data. METHOD: This study was performed as a cross-sectional analysis of a longitudinal cohort. Inclusion criteria were age over 12 months, genetically confirmed MtD. Clinical data were obtained by caregiver interview and medical records abstraction. Measures included IQ, Vineland Adaptive Behavior Scales, Third Edition, the International Pediatric Mitochondrial Disease Scale (IPMDS), and Gross Motor Functional Classification System (GMFCS) level. An exploratory approach analyzed the relationship between clinical data and other measures, using Vineland Adaptive Behavior Scales, Third Edition as a dependent variable. RESULTS: The cohort included 32 children, mean age 7 years (SD = 3 years 6 months). The most common genotypes included MT-ATP6 (n = 6) and the mitochondrial aminoacyl tRNA synthetase family of genes. Regarding phenotype, 15 out of 32 (47%) met clinical criteria for Leigh syndrome. Clinical descriptors of disability included 18 out of 32 (56%) with intellectual disability/global developmental delay; 13 out of 32 (40%) were non-ambulatory and 6 out of 32 (19%) reported developmental regression, primarily in the motor domain. The mean Full Scale IQ was 54 (SD = 27) and adaptive behavior composite (ABC) standard score was 66 (SD = 20) with motor subscale lower than other domains. The ABC was negatively associated with IPMDS, GMFCS, and seizures. Of those who walked and talked by 24 months and had neuroimaging with zero or one brain region affected (n = 9), eight (89%) had adaptive function in the average range. INTERPRETATION: Children with MtD exhibit a wide range of neurodevelopmental function. Overall MtD adaptive function was low, with motor-predominant disability, and correlated negatively with other measures of severity. Episodic developmental regression occurred in a minority of this cohort but primarily affected motor skills.

Authors

Institutions

Publication Details

Journal
Developmental Medicine & Child Neurology
Published
2026-11-02
DOI
https://doi.org/10.1111/dmcn.70598
Primary Topic
Mitochondrial Function and Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early milestones and neurodevelopment in children with mitochondrial disease

Shannon Kruk, Audrey E. Thurm, Peter J. McGuire, Eliza M. Gordon‐Lipkin et al.
Developmental Medicine & Child Neurology
Mitochondrial Function and Pathology
article

Early milestones and neurodevelopment in children with mitochondrial disease

Shannon Kruk, Audrey E. Thurm, Peter J. McGuire, Eliza M. Gordon‐Lipkin, Lisa A. Joseph, Cristan Farmer, Madeleine Hesselgesser, Maegan Wood
article en

Abstract

AIM: To quantify neurodevelopmental functioning in children with primary mitochondrial disease (MtD), and to assess relationships with other clinical data. METHOD: This study was performed as a cross-sectional analysis of a longitudinal cohort. Inclusion criteria were age over 12 months, genetically confirmed MtD. Clinical data were obtained by caregiver interview and medical records abstraction. Measures included IQ, Vineland Adaptive Behavior Scales, Third Edition, the International Pediatric Mitochondrial Disease Scale (IPMDS), and Gross Motor Functional Classification System (GMFCS) level. An exploratory approach analyzed the relationship between clinical data and other measures, using Vineland Adaptive Behavior Scales, Third Edition as a dependent variable. RESULTS: The cohort included 32 children, mean age 7 years (SD = 3 years 6 months). The most common genotypes included MT-ATP6 (n = 6) and the mitochondrial aminoacyl tRNA synthetase family of genes. Regarding phenotype, 15 out of 32 (47%) met clinical criteria for Leigh syndrome. Clinical descriptors of disability included 18 out of 32 (56%) with intellectual disability/global developmental delay; 13 out of 32 (40%) were non-ambulatory and 6 out of 32 (19%) reported developmental regression, primarily in the motor domain. The mean Full Scale IQ was 54 (SD = 27) and adaptive behavior composite (ABC) standard score was 66 (SD = 20) with motor subscale lower than other domains. The ABC was negatively associated with IPMDS, GMFCS, and seizures. Of those who walked and talked by 24 months and had neuroimaging with zero or one brain region affected (n = 9), eight (89%) had adaptive function in the average range. INTERPRETATION: Children with MtD exhibit a wide range of neurodevelopmental function. Overall MtD adaptive function was low, with motor-predominant disability, and correlated negatively with other measures of severity. Episodic developmental regression occurred in a minority of this cohort but primarily affected motor skills.

Developmental Medicine & Child Neurology
National Institutes of Health (US), National Human Genome Research Institute (US), National Institute of Mental Health (US)
Openalex Percentile: Top 24%
Mitochondrial Function and Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon